Dr. Leslie on the Development of CAR T-Cell Therapy in DLBCL and MCL
Lori A. Leslie, MD, discusses developments in CAR T-cell therapy in diffuse large B-cell lymphoma and mantle cell lymphoma.
Dr. Leslie on the Need for Clinical Trials to Address Unmet Needs in MCL
Lori A. Leslie, MD, discusses the importance of clinical trials in finding novel, up-front therapy options for patients with mantle cell lymphoma.
Dr. Leslie Discusses CAR T-Cell Therapy in MCL
Lori A. Leslie, MD, lymphoma attending, John Theurer Cancer Center, discusses the developing role of chimeric antigen receptor (CAR) T-cell therapy for patients with mantle cell lymphoma (MCL).
2 Clarke Drive Cranbury, NJ 08512